Literature DB >> 28079606

Relationship Between Alternative Resuscitation Strategies, Host Response and Injury Biomarkers, and Outcome in Septic Shock: Analysis of the Protocol-Based Care for Early Septic Shock Study.

John A Kellum1, Francis Pike, Donald M Yealy, David T Huang, Nathan I Shapiro, Derek C Angus.   

Abstract

OBJECTIVES: The Protocol-based Care for Early Septic Shock trial found no differences across alternative resuscitation strategies in all-cause mortality. A separate aim was to determine whether differences in resuscitation strategies affected trajectories of biomarkers of key pathways associated with downstream clinical outcomes of sepsis and whether there were differences in survival across treatment arms for patients with different baseline biomarker profiles.
DESIGN: Secondary analysis of a large randomized clinical trial.
SETTING: Thirty-one U.S. hospitals. PATIENTS: Six hundred twenty-eight patients with septic shock.
INTERVENTIONS: Two resuscitation protocols versus usual care.
MEASUREMENTS AND MAIN RESULTS: We measured a panel of biomarkers representing four pathophysiologic domains: "inflammation" (tumor necrosis factor, interleukin-6, and -10); "coagulation" (D-dimers, thrombin-antithrombin complex); "oxidative stress" (urine isoprostane); and "tissue hypoxia" (lactate) at 0, 6, 24, and 72 hours after treatment. We analyzed whether alternative resuscitation strategies affected biomarker trajectories over 72 hours and whether effects on 90-day hospital mortality varied by baseline (time 0) biomarker profiles-both using regression models with interaction terms for treatment arms. For all baseline biomarkers, higher concentrations were associated with increased risk of death by 90 days. However, there was no significant effect of treatment assignment on subsequent biomarker trajectories. We did find evidence for heterogeneity of treatment effect of protocol-based care on mortality for patients with different baseline [interleukin-6] and [interleukin-6] × [interleukin-10] profiles, whereas patients with the lowest quartiles fared better with protocol-based care (odds ratios, 0.32 [0.13-075]; p = 0.01 and 0.32 [0.14-0.73]; p = 0.01, respectively).
CONCLUSIONS: In patients with septic shock, alterations in inflammation, coagulation, oxidative stress, and tissue hypoxia are common and associated with adverse outcomes but are not influenced by protocol-based resuscitation compared with usual care. However, contrary to expectation, protocol-based resuscitation appeared to be superior in patients with lower concentrations of inflammatory biomarkers. The mechanisms responsible for this effect are unclear.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28079606      PMCID: PMC5448291          DOI: 10.1097/CCM.0000000000002206

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  16 in total

1.  Iso-osmolar prehydration shifts the cytokine response towards a more anti-inflammatory balance in human endotoxemia.

Authors:  Mirrin J Dorresteijn; Lucas T van Eijk; Mihai G Netea; Paul Smits; Johannes G van der Hoeven; Peter Pickkers
Journal:  J Endotoxin Res       Date:  2005

2.  A randomized trial of protocol-based care for early septic shock.

Authors:  Donald M Yealy; John A Kellum; David T Huang; Amber E Barnato; Lisa A Weissfeld; Francis Pike; Thomas Terndrup; Henry E Wang; Peter C Hou; Frank LoVecchio; Michael R Filbin; Nathan I Shapiro; Derek C Angus
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

3.  Early goal-directed therapy: do we have a definitive answer?

Authors:  Daniel De Backer; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2016-03-07       Impact factor: 17.440

4.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

Authors:  E R DeLong; D M DeLong; D L Clarke-Pearson
Journal:  Biometrics       Date:  1988-09       Impact factor: 2.571

5.  Goal-directed resuscitation for patients with early septic shock.

Authors:  Sandra L Peake; Anthony Delaney; Michael Bailey; Rinaldo Bellomo; Peter A Cameron; D James Cooper; Alisa M Higgins; Anna Holdgate; Belinda D Howe; Steven A R Webb; Patricia Williams
Journal:  N Engl J Med       Date:  2014-10-01       Impact factor: 91.245

6.  Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis.

Authors:  Jean-François Dhainaut; S Betty Yan; Benjamin D Margolis; José A Lorente; James A Russell; Ross C Freebairn; Herbert D Spapen; Hanno Riess; Bruce Basson; Gerald Johnson; Gary T Kinasewitz
Journal:  Thromb Haemost       Date:  2003-10       Impact factor: 5.249

7.  The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock.

Authors:  Emanuel P Rivers; James A Kruse; Gordon Jacobsen; Kant Shah; Manisha Loomba; Ronny Otero; Ed W Childs
Journal:  Crit Care Med       Date:  2007-09       Impact factor: 7.598

Review 8.  Inflammation, endothelium, and coagulation in sepsis.

Authors:  Marcel Schouten; Willem Joost Wiersinga; Marcel Levi; Tom van der Poll
Journal:  J Leukoc Biol       Date:  2007-11-21       Impact factor: 4.962

Review 9.  Crosstalk between inflammation and thrombosis.

Authors:  Charles T Esmon
Journal:  Maturitas       Date:  2004-04-15       Impact factor: 4.342

10.  Trial of early, goal-directed resuscitation for septic shock.

Authors:  Paul R Mouncey; Tiffany M Osborn; G Sarah Power; David A Harrison; M Zia Sadique; Richard D Grieve; Rahi Jahan; Sheila E Harvey; Derek Bell; Julian F Bion; Timothy J Coats; Mervyn Singer; J Duncan Young; Kathryn M Rowan
Journal:  N Engl J Med       Date:  2015-03-17       Impact factor: 91.245

View more
  13 in total

Review 1.  Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.

Authors:  Sadudee Peerapornratana; Carlos L Manrique-Caballero; Hernando Gómez; John A Kellum
Journal:  Kidney Int       Date:  2019-06-07       Impact factor: 10.612

2.  Prompt Administration of Antibiotics and Fluids in the Treatment of Sepsis: A Murine Trial.

Authors:  Anthony J Lewis; John E Griepentrog; Xianghong Zhang; Derek C Angus; Christopher W Seymour; Matthew R Rosengart
Journal:  Crit Care Med       Date:  2018-05       Impact factor: 7.598

3.  Fluid resuscitation targeting sepsis-induced cardiovascular dysfunction: severity of disease as effect modifier.

Authors:  Christian J Wiedermann; Stefan Dunzendorfer
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

4.  Activation of CB1R Promotes Lipopolysaccharide-Induced IL-10 Secretion by Monocytic Myeloid-Derived Suppressive Cells and Reduces Acute Inflammation and Organ Injury.

Authors:  Jérémie Joffre; Che-Chung Yeh; Erika Wong; Mayuri Thete; Fengyun Xu; Ivana Zlatanova; Elliot Lloyd; Lester Kobzik; Matthieu Legrand; Judith Hellman
Journal:  J Immunol       Date:  2020-05-08       Impact factor: 5.422

5.  A zebrafish model of infection-associated acute kidney injury.

Authors:  Xiaoyan Wen; Liyan Cui; Seth Morrisroe; Donald Maberry; David Emlet; Simon Watkins; Neil A Hukriede; John A Kellum
Journal:  Am J Physiol Renal Physiol       Date:  2018-03-14

6.  Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial.

Authors:  Peter C Hou; Michael R Filbin; Henry Wang; Long Ngo; David T Huang; William C Aird; Donald M Yealy; Derek C Angus; John A Kellum; Nathan I Shapiro
Journal:  Chest       Date:  2017-01-19       Impact factor: 9.410

7.  Sepsis Presenting in Hospitals versus Emergency Departments: Demographic, Resuscitation, and Outcome Patterns in a Multicenter Retrospective Cohort.

Authors:  Daniel E Leisman; Catalina Angel; Sandra M Schneider; Jason A D'Amore; John K D'Angelo; Martin E Doerfler
Journal:  J Hosp Med       Date:  2019-04-08       Impact factor: 2.960

8.  Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS.

Authors:  Carolyn M Hendrickson; Michael A Matthay
Journal:  Pulm Circ       Date:  2018-03-26       Impact factor: 3.017

9.  In vitro comparison of the adsorption of inflammatory mediators by blood purification devices.

Authors:  Benjamin Malard; Corine Lambert; John A Kellum
Journal:  Intensive Care Med Exp       Date:  2018-05-04

10.  Mortality Benefit of Recombinant Human Interleukin-1 Receptor Antagonist for Sepsis Varies by Initial Interleukin-1 Receptor Antagonist Plasma Concentration.

Authors:  Nuala J Meyer; John P Reilly; Brian J Anderson; Jessica A Palakshappa; Tiffanie K Jones; Thomas G Dunn; Michael G S Shashaty; Rui Feng; Jason D Christie; Steven M Opal
Journal:  Crit Care Med       Date:  2018-01       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.